12/3/2012

Data from six Liraglutide Effect and Action in Diabetes program trials showed liraglutide and other GLP-1 analogues were safe and effective in improving liver enzymes in overweight type 2 diabetes patients. Liraglutide also fared better than placebo in reducing alanine transaminase levels in patients, researchers wrote in the journal Alimentary Pharmacology and Therapeutics.

Full Story:
Modern Medicine

Related Summaries